Although IFN-γ has been shown to have potent antiviral activity against HCV in cell culture but it is not very effective in the treatment of chronic hepatitis C patients who are non-responders to IFN-α[25]. This evidence concerns the gene IFNG and chronic hepatitis C virus infection.